Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jun;46(6):2177-2185.
doi: 10.1177/0300060517748842. Epub 2018 Mar 29.

Serum neutrophil gelatinase-associated lipocalin and cystatin C are diagnostic markers of renal dysfunction in older patients with coronary artery disease

Affiliations

Serum neutrophil gelatinase-associated lipocalin and cystatin C are diagnostic markers of renal dysfunction in older patients with coronary artery disease

Hong Zhu et al. J Int Med Res. 2018 Jun.

Abstract

Objective This study aimed to assess the diagnostic value of serum neutrophil gelatinase-associated lipocalin (NGAL) and cystatin C for renal dysfunction in older patients with coronary disease. Methods A total of 84 older patients with coronary artery disease were included in this study. Serum NGAL and cystatin C levels were analysed using commercially available kits. Medical data of all patients were recorded and analysed. Results NGAL and cystatin C levels were significantly positively correlated with N-terminal prohormone of brain natriuretic peptide levels and negatively correlated with the estimated glomerular filtration rate. The areas under the receiver operating characteristic curves of serum NGAL and cystatin C levels for diagnosing early renal dysfunction were 0.884 and 0.744, respectively. Conclusion Serum NGAL and cystatin C are potential early and sensitive markers of renal dysfunction in older patients with coronary artery disease.

Keywords: Neutrophil gelatinase-associated lipocalin (NGAL); chronic heart failure; coronary artery; cystatin C; older patient; renal function.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Scatter plots showing correlations of serum NGAL or cystatin C with NT-proBNP or the eGFR (a) Correlation of serum NGAL with NTproBNP levels; (b) correlation of serum NGAL levels with the eGFR; (c) correlation of serum cystatin C with NT-proBNP levels; and (d) correlation of serum cystatin C levels with the eGFR. NGAL, neutrophil gelatinase-associated lipocalin; NT-proBNP, N-terminal prohormone of brain natriuretic peptide; eGFR, estimated glomerular filtration rate.
Figure 2.
Figure 2.
ROC curves of serum NGAL and cystatin C levels for diagnosing renal dysfunction ROC, receiver operating characteristic; NGAL, neutrophil gelatinase-associated lipocalin.

References

    1. Hoes AW, Mosterd A, Grobbee DE. An epidemic of heart failure? Recent evidence from Europe. Eur Heart J 1998; 19(Suppl L): L2–L9. - PubMed
    1. Rich MW. Heart failure in the 21st century: a cardiogeriatric syndrome. J Gerontol A Biol Sci Med Sci 2001; 56: M88–M96. - PubMed
    1. Bui AL, Horwich TB, Fonarow GC. Epidemiology and risk profile of heart failure. Nat Rev Cardiol 2011; 8: 30–41. - PMC - PubMed
    1. Ezekowitz J1, McAlister FA, Humphries KH, et al. The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease. J Am Coll Cardiol 2004; 44: 1587–1592. - PubMed
    1. Hillege HL, Nitsch D, Pfeffer MA, et al. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 2006; 113: 671–678. - PubMed

LinkOut - more resources